Preclinical Drug Development

Biotrofix specializes in preclinical efficacy studies in rodent models of neurologic and vascular diseases. These data form an essential part of the preclinical drug discovery and preclinical drug development processes. For a full list of models covered, please refer to the menu on the left hand side of the page. Biotrofix is an expert, open, accessible and collaborative partner for your preclinical research needs.

Home The Company Preclinical Research Services The Team News Publications Contact Us Site Map

Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.